A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.

ABSTRACT:

SUBMITTER: Akova M 

PROVIDER: S-EPMC8042350 | biostudies-literature | 2021 Apr

REPOSITORIES: biostudies-literature